<code id='1A10AAC9A1'></code><style id='1A10AAC9A1'></style>
    • <acronym id='1A10AAC9A1'></acronym>
      <center id='1A10AAC9A1'><center id='1A10AAC9A1'><tfoot id='1A10AAC9A1'></tfoot></center><abbr id='1A10AAC9A1'><dir id='1A10AAC9A1'><tfoot id='1A10AAC9A1'></tfoot><noframes id='1A10AAC9A1'>

    • <optgroup id='1A10AAC9A1'><strike id='1A10AAC9A1'><sup id='1A10AAC9A1'></sup></strike><code id='1A10AAC9A1'></code></optgroup>
        1. <b id='1A10AAC9A1'><label id='1A10AAC9A1'><select id='1A10AAC9A1'><dt id='1A10AAC9A1'><span id='1A10AAC9A1'></span></dt></select></label></b><u id='1A10AAC9A1'></u>
          <i id='1A10AAC9A1'><strike id='1A10AAC9A1'><tt id='1A10AAC9A1'><pre id='1A10AAC9A1'></pre></tt></strike></i>

          entertainment

          entertainment

          author:entertainment    Page View:29122
          the White House and the lawn in front of it shows behind a railing – coverage from STAT
          Mark Wilson/Getty Images

          President Biden’s executive order on artificial intelligence amounts to a giant course correction in health care. The actions taken in response could dramatically reshape how AI is used — and how much it costs — in areas from drug research to hospital care.

          The order, released in full detail late Monday, calls for two elements of AI oversight that are currently nonexistent in health care: a policy, or independent body, that would test and assure the quality of AI tools, and a “central tracking repository” to report clinical errors associated with the use of the technology.

          advertisement

          AI standards bodies in health care have previously pitched both ideas, but throwing the weight of the federal government behind them is more likely to bring them to fruition. Biden’s orders all require action before next fall’s election, a timeline designed to build momentum behind regulations that may be harder for a successor with different ideas to reverse.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more
          U.K. officials, researchers try to ease path for bespoke genetic treatments
          U.K. officials, researchers try to ease path for bespoke genetic treatments

          AdobeLONDON—Widespreadgenetictestingaswellasthedevelopmentofcutting-edge,customizedgenetictherapiesh

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Biotech investment managers search for lucrative opportunities

          Fromleft,RodNathan,portfoliomanagerandpartnerofJ.Goldman&Co.;ARKInvestsenioranalystAliUrman;andP